Skip to main content

Michael Bristow

Equibles does not estimate personal net worth.

About Michael Bristow

Michael Bristow was last confirmed as CEO at Oruka Therapeutics, Inc. (ORKA) in a filing dated April 18, 2025. Earlier roles on record: CEO at Oruka Therapeutics, Inc. (ORKA) until April 3, 2024. Oruka Therapeutics, Inc. reported in an 8-K filed April 4, 2024 that Michael Bristow resigned as Director, effective April 3, 2024. Oruka Therapeutics, Inc. reported in an 8-K filed April 4, 2024 that Michael Bristow resigned as President, Chief Executive Officer and Director, effective April 3, 2024. The proxy statement of Oruka Therapeutics, Inc. reports total compensation of $510,416 for Michael Bristow in fiscal 2024, including a base salary of $96,865. Disclosed compensation is on record for 7 fiscal years.

“ARCA biopharma, Inc. (“ARCA” or the "Company") and Dr. Michael Bristow, President, Chief Executive Officer and a member of the board of directors (the “Board”) of ARCA have mutually agreed to conclude Dr. Bristow’s employment and service as a director, effective April 3, 2024.”
Oruka Therapeutics, Inc. Form 8-K, filed April 4, 2024 · Read the filing
“ARCA biopharma, Inc. (“ARCA” or the "Company") and Dr. Michael Bristow, President, Chief Executive Officer and a member of the board of directors (the “Board”) of ARCA have mutually agreed to conclude Dr. Bristow’s employment and service as a director, effective April 3, 2024.”
Oruka Therapeutics, Inc. Form 8-K, filed April 4, 2024 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Oruka Therapeutics, Inc. (ORKA) $96,865 $510,416
2023 Oruka Therapeutics, Inc. (ORKA) $345,000 $358,800
2022 Oruka Therapeutics, Inc. (ORKA) $345,000 $358,800
2021 Oruka Therapeutics, Inc. (ORKA) $343,431 $526,513
2020 Oruka Therapeutics, Inc. (ORKA) $286,083 $1,061,587
2019 Oruka Therapeutics, Inc. (ORKA) $284,328 $296,151
2018 Oruka Therapeutics, Inc. (ORKA) $304,219 $320,490

Recent activity